Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease

Blood (2024) 143 (25): 2654–2665.

https://doi.org/10.1182/blood.2023023301

Published: 2024

Includes: Supplemental data

Journal Articles

Increased Incidence of New-Onset Diabetes Mellitus Type II Following Haploidentical Bone Marrow Transplant with Post-Transplant Cyclophosphamide for Sickle Cell Disease

Dilan A Patel, MD, Josu de la Fuente, Michael Matheney, MD, Leena Karnik, FRCPath, MRCP, Heidi Chen, PhD, Katie S. Gatwood, PharmD, Kathryn A. Culos, PharmD, Karina L Wilkerson, NP, MSN, Michael T. Byrne, DO, Salyka M. Sengsayadeth, MD, Stacey Ann Goodman, MD, Bhagirathbhai Dholaria, MBBS, Bipin N. Savani, MD, Wichai Chinratanalab, MD, Reena Jayani, MD, Jim Connelly, MD, Carrie Kitko, MD, Brian G. Engelhardt, MD, Adetola A. Kassim, MDMS

Blood (2020) 136 (Supplement 1): 20.

https://doi.org/10.1182/blood-2020-143039

Published: 2020

Journal Articles

Decreased Hospitalizations and Improved Health-Related Outcomes Using Client-Centered Therapy in Adults with Sickle Cell Disease with High Health Care Utilization

Jasmine McGhee, Karina L Wilkerson, NP, MSN, Deva Sharma, MD MS, Gina Frieden, PhD, Adetola A. Kassim, MDMS

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-143278

Published: 2020

Journal Articles

Reduction in Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Ameet Patel, MD, Karina L Wilkerson, NP, MSN, Kathryn A. Culos, PharmD, Jennifer Green, MD, Michael T. Byrne, DO, Salyka M. Sengsayadeth, MD, Bhagirathbhai Dholaria, MBBS, Bipin N. Savani, MD, Stacey Ann Goodman, MD, Wichai Chinratanalab, MD, Reena Jayani, MD, Katie S. Gatwood, PharmD, Brian G. Engelhardt, MD, Adetola A. Kassim, MDMS

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-138499

Published: 2020

Journal Articles

Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Severe Sickle Cell Disease, a Phase II Trial: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC 2 )

Adetola A. Kassim, MDMS, Josu de la Fuente, Ali Debsan Alahmari, MBBS, MD MNAMS, Michael J. Eckrich, MD MPH, Rabi Hanna, MD, Nathalie Dhedin, MD, Biljana N. Horn, MD, Vandy Black, MDMSc, Roseane V Gouveia, Adriana Seber, MDMS, Belinda Pinto Simões, MD PhD, Thalita Cristina de Mello Costa, MD, Renato Guerino-Cunha, Carmem M. S. Bonfim, MDPhD, Roberto Luiz da Silva, Nelson Hamerschlak, MD PhD, Juliana Folloni Fernandes, MD, Michael Kent, MDBS, Satya Prakash Yadav, MBBS, MD, Erfan Nur, MDPhD, Mohsen Alzahrani, Ben Carpenter, PhD, William Tse, MD, Maria Isabel, Hemalatha G Rangarajan, MD, Ibrahim Ahmed, MD, Adeseye Michael Akinsete, MBBS, Courtney D. Fitzhugh, MD, Kathryn A. Culos, PharmD, Leena Karnik, FRCPath, MRCP, James Connelly, MD, Carrie Kitko, MD, Jennifer Andrews, MDMSc, Karina L Wilkerson, NP, MSN, Robert Brodsky, Tatsuki Koyama, Michael R. DeBaun, MD MPH

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-141771

Published: 2020

Journal Articles

Decline in Forced Expiratory Volume in 1 Second in Older Adults with Sickle Cell Disease Is Similar to Adults with Cystic Fibrosis

Brock Hodges, Jodi-Anne T Stewart, BS, Mark Rodeghier, PhD, Karina L Wilkerson, NP, MSN, Adetola A. Kassim, MDMS, Michael R. DeBaun, MDMPH

Blood (2019) 134 (Supplement_1): 1012.

https://doi.org/10.1182/blood-2019-123428

Published: 2019

Journal Articles

Stable Neurocognitive Function with Improvement in Processing Speed Following Haploidentical Bone Marrow Transplant with Post-Transplant Cytoxan in Children and Adolescents with Sickle Cell Disease

Dilan A Patel, MD, Kemar V Prussien, Karina L Wilkerson, NP, MSN, Becky Armstrong, PhD, Leena Karnik, FRCPath, MRCP, Adetola A. Kassim, MDMS, Josu de la Fuente, FRCP, PhD FRCPath

Blood (2019) 134 (Supplement_1): 2277.

https://doi.org/10.1182/blood-2019-124769

Published: 2019

NARROW

An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease

Increased Incidence of New-Onset Diabetes Mellitus Type II Following Haploidentical Bone Marrow Transplant with Post-Transplant Cyclophosphamide for Sickle Cell Disease

Decreased Hospitalizations and Improved Health-Related Outcomes Using Client-Centered Therapy in Adults with Sickle Cell Disease with High Health Care Utilization

Reduction in Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Severe Sickle Cell Disease, a Phase II Trial: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC 2 )

Decline in Forced Expiratory Volume in 1 Second in Older Adults with Sickle Cell Disease Is Similar to Adults with Cystic Fibrosis

Stable Neurocognitive Function with Improvement in Processing Speed Following Haploidentical Bone Marrow Transplant with Post-Transplant Cytoxan in Children and Adolescents with Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease

Increased Incidence of New-Onset Diabetes Mellitus Type II Following Haploidentical Bone Marrow Transplant with Post-Transplant Cyclophosphamide for Sickle Cell Disease

Decreased Hospitalizations and Improved Health-Related Outcomes Using Client-Centered Therapy in Adults with Sickle Cell Disease with High Health Care Utilization

Reduction in Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Severe Sickle Cell Disease, a Phase II Trial: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC 2 )

Decline in Forced Expiratory Volume in 1 Second in Older Adults with Sickle Cell Disease Is Similar to Adults with Cystic Fibrosis

Stable Neurocognitive Function with Improvement in Processing Speed Following Haploidentical Bone Marrow Transplant with Post-Transplant Cytoxan in Children and Adolescents with Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only